INICIO

Continuation of the Revista Mexicana de Cardiología

  • Home
  • Instructions for authors
    • Instructions for authors
    • Regulations for the publication of supplements
  • Publish
  • Directory
  • Publications
    • Current issue                  
    • All issues
  • About Us
    • About the Journal            
    • Publisher Policies
    • Previous Titles
    • Editorial Management
  • Contact





2022, Number 2

Cardiovasc Metab Sci 2022; 33 (2)

Infective endocarditis following transcatheter aortic valve replacement with SAPIEN 3 prosthetic valve

Sonqui-Soto, José Pablo; Hernández-Mercado, Marco Antonio; Reyes-Corona, Jesús Antonio; Victoria-Campos, José León; Morales-Bernal, Norma Eloisa

ABSTRACT

Infective endocarditis in native valves or in surgically replaced valves has been widely reported in the literature; however, it is still in a continuous process of investigation regarding infective endocarditis in transcatheter bioprosthetic valves. We present the case of a 66-year-old female patient with the diagnosis of early infective endocarditis (IE) of percutaneous prosthetic aortic valve SAPIEN 3 who had a favorable clinical evolution and outcome with conservative treatment with antibiotics despite that in-hospital mortality incidence due to IE-TAVR, represents > 40%. The report of new cases with their different characteristics, various treatments and results obtained, is considered of great importance to support the diagnosis and medical care for future patients.
  FULL TEXT PDF  

Keywords

EI-TAVR Streptococcus mitis transesophageal echocardiogram SAPIEN 3 prosthetic valve




  • Send manuscript
  • Instructions for authors
  • Recent
  • TOP 5
  • The MACARENHA connection: a holistic approach to understand and fight the...
    2025, Vol.36, Núm. 1
  • Leptin: a description of its intriguing biology. A review. Part I
    2025, Vol.36, Núm. 1
  • Inflammation indices in chronic stable coronary artery disease
    2025, Vol.36, Núm. 1
  • Metformin in the management of non-alcoholic fatty liver disease: current...
    2025, Vol.36, Núm. 1
  • Statement from the Presidency of ANCAM and its Editorial Committee
    2025, Vol.36, Núm. 1
  • Effectiveness and safety of amphepramone in a slow release as part of the...
    2007, Vol.18, Núm. 1
  • Etiology and pathophysiology of type 2 diabetes mellitus
    2011, Vol.22, Núm. 1
  • Long QT syndrome secondary to drug interaction between hydroxychloroquine and...
    2018, Vol.29, Núm. 2
  • Early repolarization. Normal or dangerous?
    2011, Vol.22, Núm. 3
  • Official Mexican Standard NOM-030-SSA2-2009. For the prevention, detection,...
    2011, Vol.22, Núm. 3

Cardiovascular and Metabolic Science Vol. 33, Num. 2, Abril-Junio 2022. Es una publicación trimestral editada por la Asociación Nacional de Cardiólogos de México. Magdalena 135. Col. Del Valle. Del. Benito Juárez. Ciudad de México, México. C.P. 03103. Tel. 5556368002 https://www.cardiovascularandmetabolicscience.org.mx/ ancam@ancam.org.mx https://www.medigraphic.com/cms/ E-mail addresses: revmexcardiol@gmail.com Editor responsable. Dr. Eduardo Meaney Mendiolea. Reserva de Derechos al Uso Exclusivo Nº 04-2019-061316491900-203. ISSN: 2683-2828 versión impresa y 2954-3835 versión electrónica. Ambos otorgados por el Instituto Nacional del Derecho de Autor. Responsable de la última actualización de este número, Departamento de Internet, Graphimedic, S.A. de C.V., Ing. Luis Rosales Jiménez, Coquimbo 936, Col. Lindavista, Delegación Gustavo A. Madero, C.P. 07300, Ciudad de México, México. Fecha de última modificación, 04 de abril de 2024.

 

2025     |     https://www.cardiovascularandmetabolicscience.org.mx/